Ca2+ signaling in BRAF mutant tumors: therapy resistance and drug combinations  Page description

Help  Print 
Back »

 

Details of project

 
Identifier
110922
Type ANN
Principal investigator Enyedi, Ágnes
Title in Hungarian Ca2+ szignalizáció BRAF-mutáns daganatokban: terápia rezisztencia és gyógyszer kombinációk
Title in English Ca2+ signaling in BRAF mutant tumors: therapy resistance and drug combinations
Keywords in Hungarian Ca2+ szignál, Ca2+ ATPáz, BRAF, vastagbél daganat, melanóma, kombinált terápia
Keywords in English Ca2+ signaling, Ca2+ ATPase, BRAF, colorectal cancer, melanoma, combinational therapy
Discipline
Cell differentiation, physiology and dynamics (Council of Medical and Biological Sciences)40 %
Organ physiology and pathophysiology (Council of Medical and Biological Sciences)30 %
Ortelius classification: General pathology
Cancer and its biological basis (Council of Medical and Biological Sciences)30 %
Ortelius classification: Anticancer therapy
Panel Physiology, Pathophysiology, Pharmacology and Endocrinology
Department or equivalent Dept. of Pathology (Semmelweis University)
Participants Csókay, Katalin
Garay, Tamás Márton
Hegedus, Balázs
Padányi, Rita
Tímár, József
Varga, Karolina
Starting date 2014-04-01
Closing date 2017-09-30
Funding (in million HUF) 31.375
FTE (full time equivalent) 7.22
state running project





 

Events of the project

 
2017-07-25 10:06:54
Résztvevők változása




Back »